<qa>  What is the primary outcome of the prostate?To compare the efficacy of a shorter radiation fractionation schedule to the prostate 5250 cGy20 fractions over 28 days with a conventional schedule 6600 cGy33 fractions over 45 days in men receiving radiotherapy for Stage T1a moderately or poorly differentiated, or T1b, T1c, or T2 prostate cancer. The primary outcome is local control in the prostate and secondary outcomes include toxicity, disease free survival, survival, quality of life and economics. 